Phytochemicals targeting ferroptosis in cardiovascular diseases: Recent advances and therapeutic perspectives
- 8 July 2024
- journal article
- review article
- Published by Wiley in Phytotherapy Research
- Vol. 38 (9) , 4386-4405
Abstract
Ferroptosis is a form of iron‐dependent regulatory cell death that is related to the pathogenesis and progression of various cardiovascular diseases, such as arrhythmia, diabetic cardiomyopathy, myocardial infarction, myocardial ischemia/reperfusion injury, and heart failure. This makes it a promising therapeutic target for cardiovascular diseases. It is interesting that a significant number of cardiovascular disease treatment drugs derived from phytochemicals have been shown to target ferroptosis, thus producing cardioprotective effects. This study offers a concise overview of the initiation and control mechanisms of ferroptosis. It discusses the core regulatory factors of ferroptosis as potential new therapeutic targets for various cardiovascular diseases, elucidating how ferroptosis influences the progression of cardiovascular diseases. In addition, this review systematically summarizes the regulatory effects of phytochemicals on ferroptosis, emphasizing their potential mechanisms and clinical applications in treating cardiovascular diseases. This study provides a reference for further elucidating the molecular mechanisms of phytochemicals in treating cardiovascular diseases. This may accelerate their application in the treatment of cardiovascular diseases and is worth further research in this field.Keywords
Funding Information
- National Natural Science Foundation of China (82304738)
- National Natural Science Foundation of China (2024NSFSC1835)
This publication has 93 references indexed in Scilit:
- Nanosponge for Iron Chelation and Efflux: A Ferroptosis‐Inhibiting Approach for Myocardial Infarction TherapyAdvanced Science, 2024
- Suberosin Alleviates Thiazolidinedione-Induced Cardiomyopathy in Diabetic Rats by Inhibiting Ferroptosis via Modulation of ACSL4-LPCAT3 and PI3K-AKT Signaling PathwaysCardiovascular Toxicology, 2023
- Cisplatin triggers oxidative stress, apoptosis and pro‐inflammatory responses by inhibiting the SIRT1 ‐mediated Nrf2 pathway in chondrocytesEnvironmental Toxicology, 2023
- Osthole inhibits malignant phenotypes and induces ferroptosis in KRAS-mutant colorectal cancer cells via suppressing AMPK/Akt signalingCancer Chemotherapy and Pharmacology, 2023
- Matrine Alleviates Sepsis-Induced Myocardial Injury by Inhibiting Ferroptosis and ApoptosisInflammation, 2023
- Countrywide cardiovascular disease prevention and control in 49 countries with different socio‐economic statusChronic Diseases and Translational Medicine, 2022
- Corynoline protects lipopolysaccharide‐induced mastitis through regulating AKT/GSK3β/Nrf2 signaling pathwayEnvironmental Toxicology, 2021
- Icariin inhibits hypoxia/reoxygenation‐induced ferroptosis of cardiomyocytes via regulation of the Nrf2/HO‐1 signaling pathwayFEBS Open Bio, 2021
- Astragaloside IV inhibits adriamycin-induced cardiac ferroptosis by enhancing Nrf2 signalingMolecular and Cellular Biochemistry, 2021
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016